Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel Wiesweg, Clemens Aigner, Till Plönes, Kaid Darwiche, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Dirk Theegarten, Rainer Hamacher, Wilfried E.E. Eberhardt, Martin Schuler, Ken Herrmann, Wolfgang P. Fendler and Hubertus Hautzel
Journal of Nuclear Medicine August 2024, 65 (8) 1188-1193; DOI: https://doi.org/10.2967/jnumed.124.267473
Lukas Kessler
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
2Institute of Diagnostic and Interventional Radiology and Neuroradiology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Schwaning
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Metzenmacher
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim Pabst
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Siveke
4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
5Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany;
6Division of Solid Tumor Translational Oncology, German Cancer Consortium, Partner Site Essen, Essen, Germany;
7German Cancer Research Center, Heidelberg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marija Trajkovic-Arsic
5Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany;
6Division of Solid Tumor Translational Oncology, German Cancer Consortium, Partner Site Essen, Essen, Germany;
7German Cancer Research Center, Heidelberg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benedikt Schaarschmidt
2Institute of Diagnostic and Interventional Radiology and Neuroradiology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel Wiesweg
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clemens Aigner
8Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
9Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Till Plönes
7German Cancer Research Center, Heidelberg, Germany;
8Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
10Division of Thoracic Surgery, Department of Visceral, Thoracic, and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany;
11National Center for Tumor Diseases, Dresden, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; and Helmholtz-Zentrum Dresden–Rossendorf, Dresden, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaid Darwiche
12Department of Pulmonary Medicine, Section of Interventional Pulmonology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Servet Bölükbas
8Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Stuschke
13Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lale Umutlu
2Institute of Diagnostic and Interventional Radiology and Neuroradiology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Nader
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk Theegarten
14Institute of Pathology, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rainer Hamacher
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wilfried E.E. Eberhardt
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
15Division of Thoracic Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Schuler
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang P. Fendler
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hubertus Hautzel
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 8 1188-1193
DOI 
https://doi.org/10.2967/jnumed.124.267473
PubMed 
38960716

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication January 21, 2024
  • Accepted for publication May 22, 2024
  • Published online August 1, 2024.

Article Versions

  • previous version (July 3, 2024 - 09:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Lukas Kessler1,2,3,
  2. Felix Schwaning1,3,
  3. Martin Metzenmacher3,4,
  4. Kim Pabst1,3,
  5. Jens Siveke4,5,6,7,
  6. Marija Trajkovic-Arsic5,6,7,
  7. Benedikt Schaarschmidt2,
  8. Marcel Wiesweg3,4,
  9. Clemens Aigner8,9,
  10. Till Plönes7,8,10,11,
  11. Kaid Darwiche12,
  12. Servet Bölükbas8,
  13. Martin Stuschke13,
  14. Lale Umutlu2,
  15. Michael Nader1,3,
  16. Dirk Theegarten14,
  17. Rainer Hamacher3,4,
  18. Wilfried E.E. Eberhardt3,15,
  19. Martin Schuler3,4,
  20. Ken Herrmann1,3,
  21. Wolfgang P. Fendler1,3 and
  22. Hubertus Hautzel1,3
  1. 1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  2. 2Institute of Diagnostic and Interventional Radiology and Neuroradiology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  3. 3German Cancer Consortium, Partner Site Essen, Essen, Germany;
  4. 4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  5. 5Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany;
  6. 6Division of Solid Tumor Translational Oncology, German Cancer Consortium, Partner Site Essen, Essen, Germany;
  7. 7German Cancer Research Center, Heidelberg, Germany;
  8. 8Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  9. 9Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria;
  10. 10Division of Thoracic Surgery, Department of Visceral, Thoracic, and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany;
  11. 11National Center for Tumor Diseases, Dresden, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; and Helmholtz-Zentrum Dresden–Rossendorf, Dresden, Germany;
  12. 12Department of Pulmonary Medicine, Section of Interventional Pulmonology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  13. 13Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  14. 14Institute of Pathology, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
  15. 15Division of Thoracic Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  1. For correspondence or reprints, contact Lukas Kessler (lukas.kessler{at}uk-essen.de).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 2 Citations
  • 2 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma
    Manar Badarna, Zohar Keidar, Elite Arnon-Sheleg
    Seminars in Nuclear Medicine 2025 55 2
  • Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [18F]FDG Alternatives
    Priscilla Guglielmo, Cinzia Crivellaro, Angelo Castello, Carminia Maria Della Corte, Maria Pagano, Silvia Marchesi, Mario Occhipinti, Paolo Andrea Zucali, Laura Evangelista
    Molecular Diagnosis & Therapy 2025 29 1

Article usage

Article usage: July 2024 to April 2025

AbstractFullPdf
Jul 202418338051
Aug 202416168168
Sep 20245854632
Oct 2024349168
Nov 20243521812
Dec 20243092111
Jan 20252321629
Feb 20257312154
Mar 20254311458
Apr 20252512689
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (8)
Journal of Nuclear Medicine
Vol. 65, Issue 8
August 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel Wiesweg, Clemens Aigner, Till Plönes, Kaid Darwiche, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Dirk Theegarten, Rainer Hamacher, Wilfried E.E. Eberhardt, Martin Schuler, Ken Herrmann, Wolfgang P. Fendler, Hubertus Hautzel
Journal of Nuclear Medicine Aug 2024, 65 (8) 1188-1193; DOI: 10.2967/jnumed.124.267473

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel Wiesweg, Clemens Aigner, Till Plönes, Kaid Darwiche, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Dirk Theegarten, Rainer Hamacher, Wilfried E.E. Eberhardt, Martin Schuler, Ken Herrmann, Wolfgang P. Fendler, Hubertus Hautzel
Journal of Nuclear Medicine Aug 2024, 65 (8) 1188-1193; DOI: 10.2967/jnumed.124.267473
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis
  • Multicycle Dosimetric Behavior and Dose–Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Show more Clinical Investigation

Similar Articles

Keywords

  • mesothelioma
  • cancer imaging
  • FAPI
  • fibroblast activation protein
  • thoracic cancer
SNMMI

© 2025 SNMMI

Powered by HighWire